Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asad Bashey

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Cancer Treatment and Research|March 23, 2002
Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in non-myeloablative hematopoietic cell transplantationAsad Bashey
British Journal of Haematology|July 26, 2002
Adenovirus transduction to effect CD40 signalling improves the immune stimulatory activity of myeloma cellsAsad Bashey, Mark J Cantwell, Thomas J Kipps
Blood Reviews|April 21, 2016
Extramedullary acute myelogenous leukemiaMelhem Solh, Scott Solomon, Lawrence Morris, et al.
Advances in Hematology|February 24, 2016
Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant CyclophosphamideScott R Solomon, Melhem Solh, Lawrence E Morris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 30, 2018
Superior Survival of Black Versus White Patients Following Post-Transplant Cyclophosphamide-Based Haploidentical Transplantation for Adults with Hematologic MalignancyScott R Solomon, Xu Zhang, H Kent Holland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2019
Fludarabine and Total-Body Irradiation Conditioning before Ablative Haploidentical Transplantation: Long-Term Safety and EfficacyScott R Solomon, Melhem Solh, Xu Zhang, et al.
Leukemia Research|March 5, 2020
Improved Post remission survival of non- favorable risk Acute Myelogenous Leukemia (AML) patients following initial remission induction therapy with FLAG+/-Idarubicin versus 3 + 7 (Anthracycline + Cytarabine)Melhem M Solh, Scott R Solomon, Lawrence E Morris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2014
Calcineurin inhibitor--free graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide and brief-course sirolimus following reduced-intensity peripheral blood stem cell transplantationScott R Solomon, Melissa Sanacore, Xu Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2018
The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell TransplantationMelhem M Solh, Scott R Solomon, Lawrence E Morris, et al.
Bone Marrow Transplantation|November 9, 2022
Extracorporeal photopheresis (ECP) improves overall survival in the treatment of steroid refractory acute graft-versus-host disease (SR aGvHD)Melhem M Solh, Chloe Farnham, Scott R Solomon, et al.
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Cancer Treatment and Research|March 23, 2002
Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in non-myeloablative hematopoietic cell transplantationAsad Bashey
British Journal of Haematology|July 26, 2002
Adenovirus transduction to effect CD40 signalling improves the immune stimulatory activity of myeloma cellsAsad Bashey, Mark J Cantwell, Thomas J Kipps
Blood Reviews|April 21, 2016
Extramedullary acute myelogenous leukemiaMelhem Solh, Scott Solomon, Lawrence Morris, et al.
Advances in Hematology|February 24, 2016
Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant CyclophosphamideScott R Solomon, Melhem Solh, Lawrence E Morris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 30, 2018
Superior Survival of Black Versus White Patients Following Post-Transplant Cyclophosphamide-Based Haploidentical Transplantation for Adults with Hematologic MalignancyScott R Solomon, Xu Zhang, H Kent Holland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2019
Fludarabine and Total-Body Irradiation Conditioning before Ablative Haploidentical Transplantation: Long-Term Safety and EfficacyScott R Solomon, Melhem Solh, Xu Zhang, et al.
Leukemia Research|March 5, 2020
Improved Post remission survival of non- favorable risk Acute Myelogenous Leukemia (AML) patients following initial remission induction therapy with FLAG+/-Idarubicin versus 3 + 7 (Anthracycline + Cytarabine)Melhem M Solh, Scott R Solomon, Lawrence E Morris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2014
Calcineurin inhibitor--free graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide and brief-course sirolimus following reduced-intensity peripheral blood stem cell transplantationScott R Solomon, Melissa Sanacore, Xu Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2018
The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell TransplantationMelhem M Solh, Scott R Solomon, Lawrence E Morris, et al.
Bone Marrow Transplantation|November 9, 2022
Extracorporeal photopheresis (ECP) improves overall survival in the treatment of steroid refractory acute graft-versus-host disease (SR aGvHD)Melhem M Solh, Chloe Farnham, Scott R Solomon, et al.
Pageof 13